Anixa Biosciences マネジメント
マネジメント 基準チェック /24
Anixa Biosciencesの CEO はAmit Kumarで、 Jul2017年に任命され、 の在任期間は 7.33年です。 の年間総報酬は$ 3.64Mで、 19.8%給与と80.2%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.61%を直接所有しており、その価値は$ 1.72M 。経営陣と取締役会の平均在任期間はそれぞれ7.7年と6.1年です。
主要情報
Amit Kumar
最高経営責任者
US$3.6m
報酬総額
| CEO給与比率 | 19.8% |
| CEO在任期間 | 7.3yrs |
| CEOの所有権 | 1.6% |
| 経営陣の平均在職期間 | 7.7yrs |
| 取締役会の平均在任期間 | 6.1yrs |
経営陣の近況
Recent updates
We're Not Very Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Rate
Sep 12
We're Hopeful That Anixa Biosciences (NASDAQ:ANIX) Will Use Its Cash Wisely
May 23We're Not Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn
Jan 19We Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growth
Oct 06Is There An Opportunity With Anixa Biosciences, Inc.'s (NASDAQ:ANIX) 41% Undervaluation?
Apr 27Are Investors Undervaluing Anixa Biosciences, Inc. (NASDAQ:ANIX) By 36%?
Jan 13We're Interested To See How Anixa Biosciences (NASDAQ:ANIX) Uses Its Cash Hoard To Grow
Sep 26Anixa adds 11% after dosing initiation in CAR-T ovarian cancer trial
Aug 15Anixa to get additional US patent linked to breast cancer vaccine technology
Jul 21Anixa Biosciences (NASDAQ:ANIX) Is In A Good Position To Deliver On Growth Plans
Jun 13Anixa: Making Sense Of A Bullish Move Up In Bearish Biotech Times
May 11We're Interested To See How Anixa Biosciences (NASDAQ:ANIX) Uses Its Cash Hoard To Grow
Feb 24Companies Like Anixa Biosciences (NASDAQ:ANIX) Can Afford To Invest In Growth
Oct 28Our First Look At Anixa Biosciences
Sep 23Here's Why We're Not At All Concerned With Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation
Jun 12OntoChem assigns Anixa covid-19 drug discovery project to MolGenie
May 07Anixa Biosciences (NASDAQ:ANIX) Is In A Good Position To Deliver On Growth Plans
Jan 13
Anixa Biosciences, Cleveland Clinic in ovarian cancer vaccine pact
Dec 01CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | -US$12m |
| Apr 30 2024 | n/a | n/a | -US$12m |
| Jan 31 2024 | n/a | n/a | -US$11m |
| Oct 31 2023 | US$4m | US$720k | -US$10m |
| Jul 31 2023 | n/a | n/a | -US$11m |
| Apr 30 2023 | n/a | n/a | -US$11m |
| Jan 31 2023 | n/a | n/a | -US$12m |
| Oct 31 2022 | US$2m | US$631k | -US$14m |
| Jul 31 2022 | n/a | n/a | -US$14m |
| Apr 30 2022 | n/a | n/a | -US$16m |
| Jan 31 2022 | n/a | n/a | -US$15m |
| Oct 31 2021 | US$11m | US$573k | -US$13m |
| Jul 31 2021 | n/a | n/a | -US$11m |
| Apr 30 2021 | n/a | n/a | -US$9m |
| Jan 31 2021 | n/a | n/a | -US$10m |
| Oct 31 2020 | US$2m | US$522k | -US$10m |
| Jul 31 2020 | n/a | n/a | -US$10m |
| Apr 30 2020 | n/a | n/a | -US$9m |
| Jan 31 2020 | n/a | n/a | -US$9m |
| Oct 31 2019 | US$665k | US$476k | -US$12m |
| Jul 31 2019 | n/a | n/a | -US$15m |
| Apr 30 2019 | n/a | n/a | -US$18m |
| Jan 31 2019 | n/a | n/a | -US$17m |
| Oct 31 2018 | US$12m | US$425k | -US$14m |
報酬と市場: Amitの 総報酬 ($USD 3.64M ) は、 US市場 ($USD 647.72K ) の同規模の企業の平均を上回っています。
報酬と収益: Amitの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Amit Kumar (60 yo)
7.3yrs
在職期間
US$3,639,651
報酬
Dr. Amit Kumar, Ph.D. was a Director at Ascent Solar Technologies, Inc. since June 2007 until September 16, 2022 and had been its Independent Chairman of the Board since January 2011 until September 16, 20...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, Chairman & Co-Chair of CBAB | 7.3yrs | US$3.64m | 1.61% $ 1.7m | |
| President | 8yrs | US$1.97m | 0.11% $ 116.9k | |
| Senior Vice President of Engineering | 12.2yrs | US$275.00k | データなし | |
| Chief Development Officer & Chair Breast Cancer Clinical Advisory Board | 3.2yrs | データなし | データなし |
7.7yrs
平均在職期間
64.5yo
平均年齢
経験豊富な経営陣: ANIXの経営陣は経験豊富で経験豊富です（平均在職期間は7.7年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, Chairman & Co-Chair of CBAB | 12yrs | US$3.64m | 1.61% $ 1.7m | |
| Chief Development Officer & Chair Breast Cancer Clinical Advisory Board | 1.8yrs | データなし | データなし | |
| Lead Independent Director | 7.3yrs | US$169.35k | 2.84% $ 3.0m | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | 6.1yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 5.1yrs | データなし | データなし | |
| Member of Breast Cancer Clinical Advisory Board | 1.8yrs | データなし | データなし | |
| Member of SAB & Breast Cancer Clinical Advisory Board | 6.2yrs | US$169.35k | 0.36% $ 381.8k | |
| Member of Scientific Advisory Board | 6.1yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 6.1yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 6.1yrs | データなし | データなし | |
| Independent Director | 5.1yrs | US$169.35k | 0.14% $ 151.6k |
6.1yrs
平均在職期間
70yo
平均年齢
経験豊富なボード: ANIXの 取締役会 は 経験豊富 であると考えられます ( 6.1年の平均在任期間)。